generic drugs and biosimilars 101
Published 5 years ago • 2.8K plays • Length 59:48Download video MP4
Download video MP3
Similar videos
-
8:28
myeloma made simple: drug classes made simple | the main types of drug used to treat myeloma
-
4:03
what are the main classes of drugs used in myeloma?
-
0:37
j&j’s carvykti and bms’ abecma win fda approvals for earlier use in multiple myeloma
-
2:56:05
advances in myeloma treatments: what patients & caregivers need to know
-
26:28
all about abecma (idecabtagene vicleucel)
-
2:24
abecma gets chmp green light for earlier multiple myeloma treatment
-
1:02:16
getting to know the abecma (ide-cel) car t therapy
-
13:34
sdhb mouse model for pheochromocytoma
-
30:15
manufacturing concepts for antibody-drug conjugates | webinar
-
8:24
management of side effects for braf/mek inhibitors for melanoma
-
0:37
fda advisory committee backs carvykti and abecma for earlier myeloma treatment
-
3:59
should myeloma patients switch to the generic forms of medications?
-
2:17
abecma - multiple myeloma treatment
-
3:31
fda d.i.s.c.o. burst edition: fda approval of abecma (idecabtagene vicleucel) the first fda appro...
-
1:23
biosimilars – what they are and what you need to know.
-
2:53
what are immunomodulatory drugs (imids) and how do they work?
-
4:12
myc and multiple myeloma: drugging the undruggable
-
3:48
abecma car t-cell therapy for multiple myeloma
-
1:07
the biology of the plasma cell and drug targets in multiple myeloma
-
0:15
medicines of tomorrow
-
1:04
majestec-1: teclistamab for myeloma
-
1:29
the future of adcs in treating multiple myeloma